Description: ABIRISK: Anti-Biopharmaceutical Immunization: prediction and analysis of clinical relevance to minimize the RISK
ada (663) immunization (92) biopharmaceutical (54) hypersensitivity (6) neutralizing antibody (3) biopharmaceuticals immunogenicity (2) anti-drug antibody (2) immunotoxicology (2) immunogenicity of biologics (2) predictive immunogenicity (2)
Anti-Biopharmaceutical Immunization: prediction and analysis of clinical relevance to minimize the RISK
Proposed terms and definitions for reporting immunogenicity results
One of the first goals of the ABIRISK consortium was to provide clear definitions around terms and concepts related to immunogenicity, its prediction and associated clinical events.